ロード中...

Body composition and aspirin dose for colorectal adenoma prevention in a randomized clinical trial

BACKGROUND: Visceral adiposity is a risk factor for colorectal adenomas, and aspirin is an established chemopreventive agent. Evidence from clinical trials suggests the effectiveness of aspirin at preventing cardiovascular disease and cancer may require higher doses for higher body weight. METHODS:...

詳細記述

保存先:
書誌詳細
出版年:Cancer Epidemiol Biomarkers Prev
主要な著者: Passarelli, Michael N., Barry, Elizabeth L., Rees, Judy R., Mott, Leila A., Ahnen, Dennis J., Baron, John A.
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6608598/
https://ncbi.nlm.nih.gov/pubmed/31263057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-19-0205
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!